Clinical trial

Cytoflavin in the Treatment of Patients With Diabetic Polyneuropathy

NCT04649203

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2020-11-25

PhasePHASE3

Study timeline

Study start (actual)2020-11-25Date precision: day

Registry last updated2023-01-27

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetic Neuropathiesunresolved

Interventions

Cytoflavin (Inosine + Nicotinamide + Riboflavin + Succinic Acid)DRUG

PlaceboDRUG

Sponsors & collaborators

POLYSAN Scientific & Technological Pharmaceutical Companylead sponsor

Mapped research locations

Saint PetersburgRussia10 MoscowRussia2 YaroslavlRussia1 SaratovRussia1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04649203 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.